MANAGEMENT OF HIV AIDS,NORMALLY,MULTIPLE,ANTI RETROVIRAL DRUGS,ATTEMPT,CONTROL,HIV INFECTION,CLASSES,AGENTS,ACT ON,STAGES,THE HIV,LIFE CYCLE,DRUGS,VIRAL,TARGETS,HIGHLY ACTIVE ANTIRETROVIRAL,THERAPY,HAART,PATIENTS,TOTAL,HIV,FUNCTION,THE IMMUNE SYSTEM,OPPORTUNISTIC INFECTIONS,LEAD,DEATH,PARTS,THE WORLD,CHRONIC CONDITION,PROGRESSION,AIDS,INCREASINGLY,RARE,ANTHONY FAUCI,THE UNITED STATES NATIONAL,INSTITUTE,ALLERGY,INFECTIOUS DISEASES,WRITTEN,COLLECTIVE,RESOLUTE,ACTION,TO COME,FREE,GENERATION,INDEED,REACH IN,PAPER,LIVES,SAVED,ALONE,ANTIRETROVIRAL THERAPY,COMMENTARY,THE LANCET,RATHER,DEALING,ACUTE,POTENTIALLY,LIFE THREATENING,COMPLICATIONS,CLINICIANS,CHRONIC DISEASE,THE ABSENCE,CURE,PERSIST,DECADES,THE UNITED STATES,DEPARTMENT OF HEALTH AND HUMAN,THE WORLD HEALTH ORGANIZATION,OFFERING,ANTIRETROVIRAL TREATMENT,COMPLEXITY,REGIMEN,THE POTENTIAL,SIDE EFFECTS,IMPORTANCE,TAKING,PREVENT,RESISTANCE,ORGANIZATIONS,CHOICES,ANALYZING,RISKS,BENEFITS,EFFECTIVE THERAPY,NUCLEOSIDE REVERSE,INHIBITOR,NRTI,ZIDOVUDINE,THE US,FDA,SUBSEQUENTLY,DEVELOPED,COMBINATION,THE VIRUS,PERIODS,DIED,DISTINGUISH,ANTI RETROVIRAL THERAPY,TERM,HIGHLY ACTIVE ANTI RETROVIRAL,SEQUENTIAL,PUBLICATIONS,THE NEW ENGLAND JOURNAL OF,MEDICINE,HAMMER,COLLEAGUES,SUBSTANTIAL,BENEFIT,NEW CLASS,ANTI RETROVIRALS,PROTEASE INHIBITORS,INDINAVIR,CONCEPT,QUICKLY,CLINICAL PRACTICE,IMPRESSIVE,DECLINE,RATES,HOSPITALIZATION,ANTI,RETROVIRAL,CLASSIFIED,PHASE,RETROVIRUS,DRUG,COMBINATIONS,BACKBONE,NNRTI,ENTRY INHIBITORS,FUSION INHIBITORS,BINDING,FUSION,ENTRY,THE HOST,CELL,BLOCKING,MARAVIROC,ENFUVIRTIDE,AVAILABLE,CLASS,TARGETING,CO RECEPTOR,HUMAN,HELPER T CELLS,CAUTION,SHOULD,POSSIBLE,SHIFT IN,TROPISM,TARGET,ALTERNATIVE,CASES,INDIVIDUALS,MUTATION,DELTA,GENE,RESULTS,TURN,MEANS,SLOW,THE DISEASE,PREVIOUSLY,VARIANT,DOMINANT,MEMBRANE,PEPTIDE,MUST,ACTS,THE N,TERMINAL,HEPTAD REPEAT,HETERO,HELIX BUNDLE,THEREFORE,INFECTION,HOST CELLS,INHIBITORS,NUCLEOTIDE REVERSE,NTRTI,NUCLEOSIDE,NUCLEOTIDE ANALOGUES,REVERSE TRANSCRIPTION,RNA VIRUS,HENCE,INTEGRATED,THE DNA,NUCLEUS,IT MUST BE,REVERSE TRANSCRIBED,DNA,THE CONVERSION OF,RNA,DONE,MAMMALIAN,PERFORMED,VIRAL PROTEIN,INHIBITION,CHAIN,SUCH THAT,ONCE,WORK,NUCLEOSIDES,OH GROUP,COMPETITIVE,SUBSTRATE,ZIDOVUDINE ABACAVIR LAMIVUDINE,EMTRICITABINE,TENOFOVIR,NON NUCLEOSIDE REVERSE,REVERSE TRANSCRIPTASE,ALLOSTERIC,SITE,ENZYME,NON COMPETITIVE,AFFECT,HANDLING,NUCLEOTIDES,ACTIVE SITE,NEVIRAPINE,EFAVIRENZ,ETRAVIRINE,RILPIVIRINE,NATURALLY,INTEGRASE INHIBITOR,ALSO KNOWN AS,INTEGRASE,NUCLEAR,STRAND TRANSFER,INTEGRATION,INFECTED,INTEGRASE INHIBITORS,CLINICAL TRIAL,RALTEGRAVIR,FDA APPROVAL,METAL,COMPETE,IONS,THE METAL,BINDING SITE,AS OF,ELVITEGRAVIR,DOLUTEGRAVIR,PROTEASE INHIBITOR,BLOCK,PROTEASE,NECESSARY,PRODUCE,MATURE,BUDDING,PARTICULARLY,CLEAVAGE,PRECURSOR,PROTEINS,VIRUS,PARTICLES,PRESENCE,INFECTIOUS,HIV PROTEASE INHIBITORS,LOPINAVIR,NELFINAVIR,AMPRENAVIR,RITONAVIR,DARUNAVIR,ATAZANAVIR,FIRST LINE THERAPY,MATURATION INHIBITOR,SIMILAR,DEVELOPMENT OF,EXPERIMENTAL,BEVIRIMAT,VIVECON,HIGH,SECOND GENERATION,EFFECTIVE,THE LIFE,CYCLE,SHORT,DAYS,VIRAL ENTRY,REPLICATION,ASSEMBLY,RELEASE,VIRUSES,CELLS,LACKS,PROOFREADING,ENZYMES,ERRORS,CONVERTS,ERROR,RATE,CAUSE,MUTATE,GENETIC VARIABILITY,THE MUTATIONS,PARENT,ABILITY,REPRODUCE,AT ALL,ADVANTAGE,NATURAL SELECTION,SUPERIORITY,SLIP,PAST,DEFENSES,IMMUNE SYSTEM,ANTIRETROVIRAL DRUGS,THE MORE,ACTIVE,GREATER,THE POSSIBILITY,THAT ONE,MULTI DRUG RESISTANT,STRAINS,THE ERA,DIDANOSINE,ZALCITABINE,STAVUDINE,LAMIVUDINE,LEADING,MUTATIONS,COMBINATION THERAPY,DEFENDS,THUS,POOL,ANTIRETROVIRALS,CREATE,KEEP,NUMBER,OFFSPRING,REDUCE,SUPERIOR,THE DRUGS,TAKEN,THE OTHER,CONTINUE,REPRODUCTION,ANTIRETROVIRAL DRUG,TAKEN IN,ORDER,THE STANDARD,CARE,CONSIST,TRIPLE COCKTAIL,SUBJECT TO,POSITIVE,NEGATIVE,SYNERGIES,LIMITS,USEFUL,RECENT,COMPANIES,COMBINE,COMPLEX,SIMPLER,FORMULAS,FIXED,DOSE,INSTANCE,OPTIONS,PILL,DAILY,EASE,CONSISTENCY,MEDICATION,ADHERENCE,EFFECTIVENESS,LONG TERM,DEVELOPMENT,PEOPLE,ON ONE,LIFE EXPECTANCY,LEAVES,THE NEED,ARISE,TREATMENT GUIDELINES,CHANGED,OVER TIME,TREATING,HIV POSITIVE,COUNTS,CONSENSUS,WHETHER,THE NATIONAL INSTITUTE OF,RECRUITING,TRIAL,DAVID HO,ADVOCATE,HARD,APPROACH,AGGRESSIVE,THE COURSE,THE INFECTION,REVIEWS,INCREASING,MULTIDRUG RESISTANCE,ABANDONED,THE ONLY,ADVANCED,IMMUNOSUPPRESSION,LESS THAN,RANGING,TIMING,START,CORE,CONTROVERSY,MEDICAL COMMUNITY,CLARITY,ACCORD,STUDY,COUNT,VERSUS,INCREASE,RISK,TEMPRANO,LIVED,LONGER,DIAGNOSIS,WAITING,DROP,LEVEL,ARGUMENTS,LESS,RECOVERY,IMMUNE SYSTEMS,HIGHER,CANCER,ARGUMENT,PROMINENCE,TRANSMISSION,AMOUNT,IN THE BLOOD,GENITAL,SECRETIONS,DRAMATICALLY,REDUCED,PARTNER,VIRAL LOAD,HAS SEX WITH,HPTN,SERODISCORDANT,HETEROSEXUAL,COUPLES,PLANNED,EDUCATION,CONDOMS,GROUP,THE STUDY,ETHICAL,REASONS,CLEAR,ANTIVIRAL,PROTECTION,CROSS,THE CONTROL GROUP,CONSISTENT,REDUCTION,TREATMENT AS PREVENTION,THE CONCEPT,HELP,SPREAD,THE JOURNAL,SCIENCE,GAVE,THE BREAKTHROUGH,THE YEAR,SUMMARY,THE WHO,HIV TREATMENT,GUIDELINES,STATE,POOREST,SAFER,EFFICACIOUS,EVER,EXPERTS,INITIATED,NEVER BE,THE SELECTION,PRESSURE,SUPPRESSION OF,VIRAL